Publication | Closed Access
Remodeling of gp41-C34 Peptide Leads to Highly Effective Inhibitors of the Fusion of HIV-1 with Target Cells We thank Dr. Terrence R. Burke, Jr., NCI, NIH, Frederick, MD 21702-1201, for proofreading the manuscript and providing useful comments. This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Japan Society for the Promotion of Science, and the Japan Health Science Foundation.
162
Citations
0
References
2002
Year
Sc PeptidesPeptide EngineeringImmunologySix-helix Peptide BundleMolecular BiologyPeptide ScienceAnalytical UltracentrifugationImmunotherapyHuman RetrovirusAntiviral Drug DevelopmentScientific ResearchBiochemistryGp41-c34 Peptide LeadsHivTarget CellsStructural BiologyNatural SciencesPeptide LibraryAntiviral ResponseOuter SurfacePeptide TherapeuticMedicineSmall MoleculesDrug Discovery
Substitution in the outer surface of the six-helix peptide bundle improved the solubility and enhanced the anti-HIV-1 activity of SC peptides. The E and K residues at positions b, c, f, and g (see scheme) stabilize the α-helix conformation critical to inhibition; the Z residues at positions a, d, and e interact with the inner strand.